source
- Novartis licenses Alteogen’s hyaluronidase enzyme ALT-B4 in new drug delivery partnershipNovartis announced a licensing agreement with South Korean biotech Alteogen to use its hyaluronidase enzyme ALT-B4 for drug delivery applications. The enzyme will be produced using Alteogen’s prop…
- Fi recalls dog supplements over possible Salmonella contaminationFi, a New York-based company, announced a recall of its dog supplement products due to potential Salmonella contamination linked to an ingredient supplied to its manufacturer. The manufacturer has…